Check out our new preprint! A study led by Matei Banu, PGY7 Columbia Neurosurgery. We find that astrocytic-like quiescent #glioma cells are driven by distinct metabolic programs, and this treatment-resistant glioma subpop can be effectively targeted via #ferroptosis in human GBM tissue.

Really happy to share our new paper published in Nature Communications, an amazing collaboration with Brent Stockwell lab and others, demonstrating that cysteine/methionine deprivation can sensitize glioma cells to a form of cell death called ferroptosis nature.com/articles/s4146…

Excited that our new paper in Nature Communications is also highlighted in PNAS journal club Peter Canoll Brent Stockwell pnas.org/post/journal-c…

Outstanding talk by ⁦Michael Argenziano⁩ at #AANS2023 presenting our work on #GBM and #ferroptosis demonstrating how we can target resistant cancer cells. Learning from clinical trials to advance therapy! So proud of Michael, physician scientist superstar!

No-Reflow Post-Recanalization in Acute Ischemic Stroke: Mechanisms, Measurements, and Molecular Markers | Stroke ahajournals.org/doi/10.1161/ST…

#OnlineFirst: Single-cell analysis of 5-aminolevulinic acid intraoperative labeling specificity for glioblastoma. thejns.org/view/journals/….

Incredibly grateful and excited to be joining the Columbia Neurosurgery team. Thank you Dr. Jeffrey Bruce, Peter Canoll , Matei Banu, Michael Argenziano, Columbia Neurosurgery, Columbia Translational Brain Tumor Laboratory for the incredible mentorship and support!

Damian’s up next!